QGAI Quantum Genesis AI Corp.
Industrial Organic Chemicals · OTC · SEC CIK 1663038 · Fiscal year ends 07/31
Financial factors as of 2026-04-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-2,095.8%
TTM EPS YoY-1,995.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-1,381,839.5%
ROIC (approx.)—
Asset turnover0.00x
Leverage & solvency
Liabilities / assets751,378.0%
Debt / equity—
Current ratio0.00x
Interest coverage-3.78x
Cash quality & payout
Operating cash flow / net income0.02x
Accruals ratio-1,359,573.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-07-31 | FY20242024-07-31 | FY20182018-07-31 | FY20172017-07-31 | FY20162016-07-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $0 | $0 | $93,550 | $128,147 | $121,327 |
| Cost of revenue | — | — | $89,345 | $105,847 | $103,860 |
| Gross profit | — | — | $4,205 | $22,300 | $17,467 |
| SG&A expense | $18,129 | $31,727 | — | — | — |
| Operating income | -$180,537 | -$163,593 | — | — | — |
| Interest expense | $21,232 | $14,976 | — | — | — |
| Pretax income | -$199,269 | -$178,569 | -$28,167 | -$38,657 | -$4,403 |
| Income tax | $0 | $0 | — | -$5,799 | — |
| Net income | -$199,269 | -$178,569 | -$28,167 | -$32,858 | -$3,743 |
| EPS (basic) | — | — | 0.00 | 0.00 | 0.00 |
| EPS (diluted) | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 35.12M | 34.74M | 5.01M | 5.01M | 4.00M |
| Balance sheet | |||||
| Cash & equivalents | $584 | $0 | — | $2,744 | $221 |
| Current assets | $584 | $10,000 | — | $7,448 | $221 |
| PP&E, net | — | — | — | $10,595 | $11,175 |
| Total assets | $584 | $10,000 | $0 | $18,043 | $11,396 |
| Current liabilities | $441,301 | $293,298 | $8,524 | $100 | $1,195 |
| Total liabilities | $441,301 | $293,298 | $8,524 | $100 | $1,195 |
| Shareholders' equity | -$440,717 | -$283,299 | -$8,524 | $17,943 | $10,201 |
| Shares outstanding | 38.96M | 34.78M | 5.01M | 5.01M | 4.00M |
| Cash flow statement | |||||
| Operating cash flow | -$125,181 | -$101,637 | -$2,744 | -$38,077 | -$3,823 |
| Capital expenditure | — | — | $11,900 | — | — |
| Free cash flow | — | — | -$14,644 | — | — |
| Financing cash flow | $125,765 | $101,637 | — | $40,600 | — |
| Depreciation & amortization | — | — | $435 | $580 | $580 |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.